Blood Product Development

The University of Texas System is a leading public university system in the United States, dedicated to improving lives through education, health care, and research. With over 256,000 students enrolled across 14 institutions, the UT System is committed to providing affordable access to higher education and producing a skilled workforce to drive Texas's economy.

The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization dedicated to advancing the bioeconomy of the United States. Its mission encompasses enhancing manufacturing, healthcare, and education and workforce development, aiming to create a scalable and effective manufacturing ecosystem for engineered cells, tissues, and organs.

Vascarta Inc. is a pharmaceutical company that has developed a patented topical/transdermal delivery platform aimed at improving the bioavailability of drugs, particularly curcumin, a compound known for its anti-inflammatory and antioxidant properties. The company focuses on addressing unmet medical needs through innovative formulations that enhance therapeutic efficacy and patient outcomes.

Stream Biomedical, Inc. is a clinical-stage biopharmaceutical company focused on developing first-in-class targeted therapeutics for acute neurotrauma and chronic neurodegenerative diseases. The company is dedicated to revolutionizing cerebrovascular repair and developing novel solutions for neurotrauma and neurodegeneration, including conditions such as stroke, traumatic brain injury, and Alzheimer's disease.

FluidForm Bio™ is revolutionizing medicine through its patented FRESH™ technology, which enables the bioprinting of living human tissue for advanced cell therapy and disease treatment. Founded in 2018, the company integrates innovations in 3D printing, synthetic biology, and AI to create tissue that closely resembles natural human tissue, aiming to improve patient outcomes and transform healthcare.

Humanetics Corporation is a clinical-stage pharmaceutical company based in Minneapolis, Minnesota, focused on developing and commercializing products to enhance human health and wellbeing. Founded in 1988, the company specializes in radiation modulators, adjunctive oncology therapies, and pulmonary protective therapies, particularly for COVID-19. Humanetics is known for its lead drug candidate, BIO 300, which is being developed as a radioprotectant for military and civilian use, as well as a treatment to improve outcomes in cancer patients receiving radiotherapy. The company is actively engaged in research programs for non-small cell lung cancer, prostate cancer, and head and neck cancers.

Teleflex is a global provider of medical technologies designed to improve the health and quality of people's lives. The company focuses on purpose-driven innovation to empower healthcare professionals and enhance patient outcomes across various medical fields.

Qidni Labs Inc. is dedicated to making dialysis technology more accessible for patients with kidney failure. With a mission to provide innovative solutions, they aim to serve the 10 million patients who currently lack access to dialysis treatment.

GreenLifeTech is dedicated to improving sustainability by extending the shelf life of fresh produce, thereby reducing food waste and promoting healthier living. In addition, the technology is applicable to preserving transfusion blood. Their initial innovative product, FreshDefend™, is a smart countertop system that can extend the life of fruits and vegetables by up to five times without the use of harmful chemicals. The company is committed to environmental sustainability, reducing agricultural waste, and supporting communities through charitable donations.

Altra Inc. is at the forefront of revolutionizing infusion therapy with its innovative Altra Infusion System. The company is dedicated to addressing the critical challenges in the infusion industry, such as mechanical failures, flow issues, and false alarms, which contribute to a significant portion of medication errors and adverse drug events. Altra's mission is to ensure patient safety and improve healthcare delivery through advanced technology solutions.

SanaHeal is dedicated to developing next-generation bioadhesive technologies inspired by nature to solve significant challenges in healthcare. Their innovative solutions are designed to adhere to wet and uneven surfaces, providing rapid and robust adhesion for various medical applications.

UTMB is dedicated to supporting research, education, and scholarly endeavors, with a focus on creating the future of healthcare through innovative research and community engagement.

Advanced BioScience Laboratories, Inc. (ABL) is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics, and other biologic products. ABL leverages its expertise in product development, GMP manufacturing, and immunological testing to support the development of candidate vaccines and therapeutics through preclinical and clinical stages. The company is involved in producing and testing oncolytic viruses, gene therapies, immunotherapies, viral vaccines, and recombinant protein vaccines.

Arsenal Medical is dedicated to transforming medical devices with innovative biomaterials. Founded by Carmichael Roberts, Robert Langer, and George Whitesides, the company aims to address unmet medical needs through thoughtfully designed products. Their vision is to provide local therapy for important medical conditions across various therapeutic areas, leveraging expertise in materials science and chemistry.

The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.

Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.

DLH delivers improved health and national security readiness solutions for federal programs through science research and development, systems engineering and integration, and digital transformation. With over 3,200 employees, DLH is committed to solving complex problems faced by civilian and military customers, leveraging advanced technologies and methodologies to enhance health outcomes and operational readiness.

Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.

Gladstone Institutes is an independent biomedical research organization dedicated to tackling the biggest challenges in human health. By disrupting traditional scientific methods, Gladstone aims to make groundbreaking discoveries that can transform lives. The organization is renowned for its innovative approaches in research, focusing on conditions with significant medical, economic, and social impacts. Founded in 1979 from a donation by J. David Gladstone, the institute has expanded its research areas to include cardiovascular, neurological, and viral diseases, as well as data science and biotechnology.

NuShores Biosciences LLC, founded in 2014, is dedicated to commercializing patented bone and tissue regeneration technologies developed at the University of Arkansas at Little Rock. The company aims to improve the quality of life for individuals with severe tissue regeneration needs through innovative solutions like the NuCress™ bone scaffold technology, which is designed to promote healing in large segmental bone defects.

Vivosang Inc is an investigational stage biotechnology company focused on developing pegylated human hemoglobin products to enhance oxygen delivery in medical applications, particularly in traumatic hemorrhagic injuries. Their lead product, VS-101, aims to provide targeted oxygen delivery to tissues in need, addressing significant medical needs in emergency and surgical settings.

The Molinaroli College of Engineering and Computing at the University of South Carolina fosters innovation by preparing engineers and computing professionals to develop new technologies that will improve lives and the world. The college is committed to addressing real-world challenges through education, research, and community engagement.

PPD, a clinical research business of Thermo Fisher Scientific, is a leading provider of global contract research organization (CRO) solutions. The company is dedicated to helping clients accelerate the development of life-changing therapies through comprehensive drug development, laboratory, and lifecycle services. With a commitment to operational excellence and innovative technology, PPD empowers its customers to bring therapies to market faster and improve patient health. PPD has been recognized as an industry leader in clinical development digital transformation services and patient engagement digital transformation. With over 30 years of clinical leadership and a workforce of more than 30,000 employees globally, PPD has conducted over 2,100 trials in the past five years.

Abram Scientific focuses on precision blood management to improve clinical outcomes through innovative diagnostic solutions. Their flagship product, the CoagCare platform, offers rapid and accurate blood coagulation diagnostics, enhancing patient care in critical situations.

Limax Biosciences is dedicated to revolutionizing tissue healing through innovative biomaterials inspired by the natural slime of slugs. Their hydrogels provide superior adhesion and healing capabilities, addressing unmet medical needs both inside and outside the body.

Cellphire Therapeutics is a clinical stage biotechnology company focused on developing next-generation allogeneic cellular therapeutics to address significant unmet needs in hemostatic treatments. With innovative products like Thrombosomes® and Cryopreserved Platelets, Cellphire aims to revolutionize bleeding management and improve patient outcomes across various clinical settings.

Machina Medical is dedicated to revolutionizing hemostatic care technology, aiming to save lives and limbs by providing innovative solutions for controlling blood loss. Their flagship product, MFUSE, is designed to address the critical need for rapid and effective bleeding control in various emergency situations.

Lankenau Institute for Medical Research (LIMR) is a leading research institute dedicated to studying and developing remedies for cancer, cardiovascular, autoimmune, gastrointestinal, and other diseases. LIMR is at the forefront of the immunotherapy revolution in healthcare, driven by the principle that hope in medicine springs from research. The institute combines a unique mix of academic culture and entrepreneurial spirit, known as the ACAPRENEURIAL™ strategy, to integrate non-profit research with for-profit biotechnology initiatives, fostering a collaborative environment for translating preclinical discoveries into clinical applications.

Solventum is a healthcare company dedicated to enabling better, smarter, and safer healthcare solutions. With a legacy of innovation, Solventum focuses on improving patient outcomes through advanced medical technologies, oral care solutions, health information technology, and purification and filtration systems.

Terumo Blood and Cell Technologies is a global leader in medical technology, specializing in blood and cell-based therapies. With over 7,900 team members, the company is dedicated to advancing healthcare by providing innovative solutions for blood collection, processing, and storage. Their mission is to empower healthcare providers with the tools and insights needed to deliver high-quality care to patients worldwide. Terumo BCT is committed to unlocking the potential of blood and cells, offering a range of products and services that support lifesaving transfusions and next-generation therapies for diseases like cancer. The company is part of the Terumo Group, which has been contributing to society through healthcare for over a century.

Enzyre is dedicated to revolutionizing blood coagulation management through innovative near patient diagnostics. Their flagship product, the ENZYPAD, enables real-time blood coagulation analysis, empowering patients and healthcare professionals with immediate access to critical data for better therapy management.

The Armed Forces Institute of Regenerative Medicine (AFIRM) , led by the Wake Forest Institute for Regenerative Medicine, is a collaborative effort involving over 30 academic institutions and industry partners. The consortium focuses on advancing regenerative medicine solutions for battlefield injuries, aiming to improve the lives of wounded service members, veterans, and the general public. With a $40 million, five-year award from the Defense Health Agency, AFIRM is dedicated to developing clinical therapies in areas such as craniofacial regeneration, extremity regeneration, genitourinary/lower abdomen, skin and wound healing, on-demand blood, and cellular therapies for trauma.

Nytricx, Inc. is dedicated to combating medical device infections and thrombosis through innovative nitric oxide (NO)-releasing biomaterials. Their technology aims to enhance the functional lifetime of medical devices by reducing infection and thrombotic events, leveraging the natural antimicrobial properties of nitric oxide.

Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world, dedicated to providing high-quality, patient-centered care. With a history of innovation spanning nearly 150 years, Mayo Clinic is committed to transforming healthcare through research, education, and compassionate care, ensuring that the best possible treatment is available to everyone.

Gryphon Bio is a clinical stage company focused on developing novel blood tests for brain health, leveraging over 20 years of -omic research to identify brain-specific biomarkers in the blood. Their mission is to improve patient lives through innovative diagnostics for various central nervous system (CNS) diseases.

InFlo Medical is developing the first fully portable extracorporeal membrane oxygenator (ECMO) technology, the MOBYBOX. Weighing only 10 lbs and entirely powered by compressed gas, the MOBYBOX offers best-in-class gas exchange in a highly biocompatible and miniaturized package.

DesiCorp, Inc. is pioneering the development of thermally stable packed red blood cells, revolutionizing battlefield medicine and blood transfusion technology. Their innovative solutions enable rapid and reliable care, allowing medics to administer life-saving transfusions within minutes of injury. With advancements that allow blood to be stored for years, DesiCorp is addressing critical medical challenges in trauma care.

Cresilon is a Brooklyn-based biotech company dedicated to saving lives through innovative hemostatic solutions. Their mission is to provide safe, effective, and reliable products that stop bleeding quickly, utilizing plant-based technology to revolutionize wound care in both veterinary and human medicine.

Guide Biomedical Solutions, LLC, also known as Guide-Bio, provides comprehensive tech advisory services for FDA-regulated manufacturers. The company is a proud member of key U.S. Government R&D and manufacturing consortia, offering wrap-around services from pursuit to post-market surveillance. Guide-Bio has a strong track record of helping clients secure significant non-dilutive funding and supports various biotech and life science organizations through strategic alliances and business development.

Safi Biotherapeutics is dedicated to developing on-demand blood cell therapies tailored for individuals in need. As a commercialization partner for a Department of Defense program, the company focuses on overcoming challenges in cell therapy manufacturing, ensuring high consistency and economic viability.

Southwest Research Institute (SwRI) is a nonprofit research and development organization that provides independent, premier services to government and industry clients. Founded in 1947, SwRI is committed to advancing science and technology to benefit humanity, focusing on innovative solutions that improve human health and safety. With a diverse range of technical divisions, SwRI addresses complex challenges in various fields including mechanical engineering, materials, aerospace, automotive, biomedical, and more.

ARMR Systems, Inc. is dedicated to revolutionizing trauma care by engineering simple solutions to complex challenges. The company focuses on creating hemorrhage control systems that enhance the survivability of traumatic pre-hospital injuries, especially in situations where advanced medical help is not immediately available. Their mission is to democratize access to care and empower first responders, ensuring that anyone, regardless of their location or background, can confidently respond to emergencies. ARMR Systems champions a new approach to trauma care and preparedness, aiming to replace barriers to access with systems of equity.

Sempulse is a pioneering company that empowers medical professionals with advanced non-invasive monitoring technology. Their flagship product, the Halo Vital Signs Monitor, allows for real-time tracking of multiple patients' vital signs from a single device, enhancing patient care and operational efficiency in various healthcare settings. Sempulse's mission is to improve patient outcomes through innovative technology that integrates seamlessly into existing healthcare systems.

Swaza Inc. is a biotechnology company focused on developing revolutionary oxygen nanotherapeutics. Their mission is to provide innovative solutions for respiratory distress through non-invasive nanofluid breathing aids and advanced regenerative biomaterials, leveraging their proprietary nanotechnology platform.

Phlow Corporation is a U.S.-based public benefit pharmaceutical manufacturing company dedicated to revolutionizing the production of essential medicines. By leveraging advanced manufacturing processes, Phlow aims to ensure the availability of high-quality, affordable pharmaceuticals and active pharmaceutical ingredients (APIs) domestically. The company is committed to reshoring pharmaceutical manufacturing to the United States, thereby enhancing the nation's healthcare security and reducing dependency on foreign supply chains. Phlow's mission is to provide every American with access to essential medicines, supporting public health and national security. The company also emphasizes sustainability and community engagement, integrating green chemistry and continuous manufacturing to reduce environmental impact and improve the sustainability of pharmaceutical production.

Coagulo Medical Technologies is transforming medicine with the first portable and connected precision-medicine platform for smarter management of coagulation, enabling better healthcare outcomes for everyone. The company combines patent-pending coagulation assays, cutting-edge microfluidic technology, and proprietary data analytics to deliver accessible and personalized diagnosis and management of coagulation-related diseases.

AvantGuard is pioneering a new era in surface protection, focusing on innovative antimicrobial technologies to combat pathogens, bacteria, viruses, fungi, and mold on various surfaces, including skin. Their mission is to reserve oral antibiotics for critical situations by providing effective surface protection solutions.

Admetsys is pioneering the future of critical care through high-precision automation, adapting to individual patient needs and implementing clinician-set goals automatically. Their innovative clinical robotics system is designed for blood analysis and metabolic control in critical care and surgery, aiming to improve patient outcomes and reduce clinical workload.

The Southwest Texas Regional Advisory Council (STRAC) is dedicated to developing, implementing, and maintaining a regional trauma and emergency healthcare system for the 22 counties in Trauma Service Area – P. STRAC aims to reduce death and disabilities related to trauma, disaster, and acute illness through well-coordinated emergency response systems, striving to be a model for emergency healthcare in the United States.

North American Rescue (NAR) is dedicated to decreasing preventable death by providing the most effective and highest quality mission critical medical products to military, federal agencies, civilian law enforcement, EMS, and pre-hospital life savers. NAR designs, develops, and tests products based on Tactical Combat Casualty Care (TCCC) guidelines, ensuring they meet the evolving needs of first responders and healthcare providers. NAR is committed to quality, with a focus on American-made products and adherence to the highest industry standards.

Macro Biologics, Inc. is dedicated to designing, patenting, and producing macro biologics, which are large molecule biologics with both physical properties and functional activities. These biologics are composed of natural building blocks, such as amino acids or carbohydrates, and are designed to degrade back into their natural components, making them environmentally friendly. The company aims to address significant global challenges, such as antibiotic resistance and pollution, by providing biologics that are safe for both people and the environment. Macro Biologics is committed to the highest standards of science, medicine, and business, with a focus on healthcare applications.

The University of Arizona Applied Research Corporation (UA-ARC) is a non-profit organization affiliated with the University of Arizona, dedicated to leveraging the university's strengths in research and education to address national security challenges. UA-ARC aims to deliver innovative solutions and foster collaborations between academia, industry, and government.

Frontier Bio creates lab-grown human tissues to eliminate the organ transplant list and as an ethical alternative to animal studies. They're starting with blood vessels since they are the foundation for all tissues.

Latham BioPharm Group (LBG), now part of Sia Partners, is a consulting firm that provides specialized expertise across various life sciences sectors. The company is dedicated to helping innovative life sciences companies overcome complex scientific and business challenges. LBG offers a client-centric approach, adapting to the strategic direction and objectives of its clients to deliver meaningful analysis and quantifiable results. The firm is known for its scalable and flexible solutions that advance products and programs in the life sciences industry.

The Institute for Biohealth Innovation (IBI) at George Mason University unites over 300 faculty and thousands of students across 34 departments to advance human health and well-being through innovative research. The IBI focuses on major health challenges, including infectious diseases, cancer, brain and behavior, and cardiovascular health, collaborating with national and international partners to implement solutions that enhance health outcomes.

The University of Minnesota's Research and Innovation Office (RIO) serves as a central resource for conducting, managing, and sponsoring research. It aims to facilitate collaborative research that addresses complex problems and promotes innovations that improve lives. RIO oversees research compliance and administration, fostering a culture of integrity and ethical practices in research. Additionally, RIO is committed to enhancing research capacity through various funding opportunities and strategic initiatives, including the management of specialized facilities for biocontainment research.

Cayuga Biotech is dedicated to harnessing the body's innate ability to halt bleeding and heal, addressing significant unmet needs in hemorrhage control and bleeding disorders through proprietary science and innovative solutions.

Vasomune Therapeutics is a private clinical-stage biopharmaceutical company focused on developing novel therapeutics for diseases associated with vascular dysfunction. Their lead drug candidate, AV-001, aims to enhance the body's ability to defend against illness by stabilizing the vascular endothelial response to disease, particularly in conditions like Acute Respiratory Distress Syndrome (ARDS).

RedC Biotech is a pre-clinical, development stage company focused on saving lives worldwide by developing a process to create universal red blood cells from stem cells. Their innovative technology aims to address the global shortage of blood transfusions by providing a safe, clean, and cost-effective alternative to traditional donor-based blood supplies.

SurgiBox Inc. is transforming surgical care with award-winning, patented technology designed to make safe surgery possible anytime, any place. Our flagship product, SurgiField, is an ultra-portable, battery-powered solution that enables safe, clean surgical conditions - from private clinics to the most hard-to-reach austere settings, namely disaster and conflict zones. Built on years of research and collaboration with leading clinicians, SurgiField integrates seamlessly into existing surgical workflows and meets the highest regulatory standards, including ISO 13485 compliance and approval in Japan, with pending imminent CE Mark certification under EU MDR. Founded by Harvard Medical School-educated clinicians and incubated at MIT D-Lab, SurgiBox is committed to making surgery safer, more accessible, and more adaptable worldwide.

Northwestern University is a prestigious institution dedicated to fostering a diverse and inclusive environment, promoting academic excellence, and engaging in impactful research. With campuses in Evanston, Chicago, and Doha, Qatar, Northwestern emphasizes global engagement and community involvement, preparing students to tackle complex challenges through interdisciplinary collaboration and innovative thinking.

Case Western Reserve University is dedicated to solving the biggest issues of today and tomorrow through innovative research and education. With a commitment to experiential learning, the university offers a wide range of programs and opportunities for students to engage in research, internships, and community service, all within a vibrant campus located in Cleveland, Ohio.

Haima Therapeutics is a pre-clinical stage biopharma company focused on developing cell-inspired therapies for the treatment of bleeding and various blood-related diseases. Their lead technology, SynthoPlate, is a novel, fully-synthetic hemostatic agent designed to mitigate bleeding by enhancing the body's natural clotting mechanisms at the site of injury.

Modulim is dedicated to preserving tissue health by empowering clinicians with actionable microvascular and data insights for the lower limb. Their innovative technology solutions aim to reduce complications related to diabetes, kidney disease, and peripheral arterial disease, ultimately improving patient outcomes and satisfaction.

The University of Missouri is dedicated to advancing research, innovation, and impact through a comprehensive support system for faculty, students, and staff. It aims to foster collaboration, enhance economic development, and promote entrepreneurship, while ensuring compliance with research regulations and ethical standards. The university also emphasizes the importance of interdisciplinary partnerships and provides resources to support veteran entrepreneurs through programs like the Entrepreneurship Bootcamp for Veterans.

Viscus Biologics LLC specializes in product realization from ideation to high volume production, manufacturing components, devices, and products with natural polymer and extracellular matrix materials. The company aims to fulfill patient and market needs, improve quality of life, and restore tissue to a healthy state.

MLM Biologics Inc. is dedicated to advancing wound care through innovative solutions like the bio-ConneKt® Wound Matrix, a collagen-based product designed for effective wound closure. The company emphasizes a mission of providing more effective and economical solutions for wound healing, aligning with the Gandhian Economic Principle of 'More for Less for Many.'

The University of Massachusetts Lowell (UML) is dedicated to providing a comprehensive educational experience that prepares students for success in their careers and lives. With over 200 degree programs and a commitment to research and community engagement, UML fosters a vibrant learning environment for its diverse student body.

Astek Diagnostics is a precision diagnostics company focused on revolutionizing the detection and treatment of bacterial infections. Their flagship product, the JIDDU system, offers rapid and accurate diagnostics for urinary tract infections (UTIs) and antibiotic sensitivity within one hour. This innovation aims to improve patient outcomes by reducing complications, healthcare costs, and antimicrobial resistance. Astek is committed to expanding its diagnostic capabilities to include multiple sample types, including urine, cerebrospinal fluid (CSF), effluent, and blood, with a market launch planned for 2025.

RTI International is an independent nonprofit research institute dedicated to improving the human condition. With a vision to address the world's most critical problems through science-based solutions, RTI integrates expertise across social and laboratory sciences, engineering, and international development to deliver reliable data, thorough analysis, and innovative methods that inform public policy and practice.

MassBiologics, part of UMass Chan Medical School, is the only nonprofit, FDA-licensed manufacturer of vaccines and biologics in the United States. With over 100 years of experience, it is dedicated to improving public health through the research, development, and production of biologic products, including vaccines and monoclonal antibodies.

TDA Research, Inc. is dedicated to addressing complex real-world problems through innovative research and development in chemical processes, materials, and hardware. With a focus on agility and collaboration, TDA partners with clients in defense, aerospace, energy, and chemical industries to deliver cutting-edge solutions and technologies.

SeaStar Medical is a medical technology company focused on redefining extracorporeal therapies to mitigate the effects of excessive inflammation on vital organs. Their innovative solutions, particularly the Selective Cytopheretic Device (SCD), aim to improve outcomes for critically ill patients by addressing dysregulated immune responses that can lead to severe complications such as acute kidney injury and multi-organ failure.

CytoSorbents is dedicated to advancing blood purification technology through innovative solutions that address critical health challenges. Their proprietary bead technology effectively removes harmful substances from the blood, providing healthcare professionals with powerful tools to improve patient outcomes in various medical conditions. The company is also focused on expanding its product offerings to include solutions for organ perfusion and antithrombotic removal. CytoSorb therapy is recognized for its ability to stabilize macro-hemodynamics, improve tissue perfusion, protect vital organs, and reduce bleeding complications, leading to enhanced patient recovery and high survival rates. CytoSorb is particularly effective in critical care settings, addressing systemic hyperinflammation and improving outcomes in patients with conditions such as septic shock and acute respiratory distress syndrome (ARDS). Additionally, CytoSorbents emphasizes the importance of training and education for healthcare professionals, ensuring they are equipped with the knowledge and skills to effectively utilize their technologies.

Orgenesis Inc. is dedicated to unlocking the potential of cell and gene therapies (CGTs) by providing affordable and accessible solutions. The company focuses on overcoming the challenges of processing personalized CGTs locally to impact patients globally. Through its POCare Platform, Orgenesis aims to lower costs and standardize high-quality CGTs, making advanced therapies more accessible to patients worldwide.

The Clemson University Research Foundation (CURF) is dedicated to advancing the research enterprise at Clemson University by connecting faculty and students with industry partners. CURF facilitates the commercialization of university technologies, supports research collaboration, and promotes innovation through various funding and support programs.

Hemerus Medical, LLC specializes in designing and developing innovative blood collection, processing, preservation, and storage technologies. Their mission is to improve patient transfusion outcomes and ensure the availability of high-quality, life-saving blood products. Hemerus aims to extend the shelf life of blood products and enhance transfusion safety through advanced technologies like leukocyte reduction filters and novel anticoagulant solutions.

MACH32 is an Edmonton-based start-up focused on creating innovative medical devices aimed at solving global health problems.

Augusta University is a comprehensive research university located in Augusta, Georgia, offering a world-class academic and social community. It is dedicated to training the next generation of innovators, leaders, and healthcare providers through a wide range of programs in medical, dental, and health sciences, as well as liberal arts, business, and cybersecurity. The university is committed to creating a culture of engagement and collaboration, fostering partnerships with the community, and advancing human health through innovative research and education.

Velico® is a private, clinical stage medical technology company headquartered in Beverly, Massachusetts, dedicated to reducing preventable death from bleeding through innovative blood and plasma products. Their flagship product, FrontlineODP™, is a novel dry plasma manufacturing system designed for rapid rehydration and transfusion in emergency settings, aiming to improve patient access to life-saving treatments.

Radiatric Inc. is dedicated to developing and commercializing innovative technologies to improve outcomes for patients with bacteremia, moderate to severe sepsis, and septic shock. Their flagship product, the RAD-01 system, is a non-antibiotic investigational device designed to treat bloodborne infections by lowering pathogenic CFUs in extracorporeal blood. The company focuses on non-pharmacological methods to deactivate pathogens, aiming to reduce the mortality and long-term effects associated with sepsis.

Rochal Industries is a global leader in commercializing technology innovations in natural and synthetic polymers, antimicrobials, and biological systems. Established in 1986, the company focuses on wound and skin care, driving its pipeline from concept to preclinical and clinical development while meeting quality and regulatory requirements.

LSU Health Sciences Center New Orleans is dedicated to educating future health professionals and scientists, advancing research, and providing exceptional healthcare. With six professional schools and numerous affiliated hospitals, LSUHSC-NO aims to improve health outcomes and address health equity challenges in Louisiana.

Creare is a leading innovator in technology and product development, specializing in engineering research and development services. With over 50 years of experience, Creare combines sophisticated analytical methods with creative engineering to solve complex challenges across various sectors, including biomedical systems, cryogenics, fluid dynamics, and advanced manufacturing. The company is dedicated to delivering innovative solutions that enhance product functionality, reduce costs, and accelerate time-to-market for its clients. Technology commercialization has been a key part of Creare’s mission since its founding in 1961, leading to significant revenue generation through licensing and spin-offs.

RegenMed Development Organization (ReMDO) is a 501(c)3 non-profit organization dedicated to accelerating the discovery and translation of regenerative medicine therapies. By conducting research to de-risk technologies and promoting biomanufacturing scale-up and automation, ReMDO aims to make regenerative medicine technologies more affordable and expedite their transition to clinical practice. The organization collaborates with thought leaders, research centers, and companies to advance the field and improve patient outcomes.

Imbed Biosciences is a privately held medical device company that specializes in the development of advanced devices for the treatment of burns, ulcers, and soft-tissue repair. The company is committed to providing innovative solutions that improve patient care and outcomes through its patented Microlyte® Matrix technology.

Perfusion Medical is dedicated to commercializing PEG-20k, a revolutionary drug designed to treat hemorrhagic shock and other ischemic conditions. With over $18 million in funding from the Department of Defense and numerous studies supporting its efficacy, the company aims to improve patient outcomes significantly.

Applied Research Associates, Inc. (ARA) is a globally recognized scientific research and engineering company dedicated to solving critical national problems to improve safety, security, and quality of life. Founded in 1979, ARA is 100% employee-owned and offers innovative technologies and solutions across various sectors, including national security, infrastructure, health solutions, and energy & environment. The company is committed to delivering mission-critical solutions that exceed expectations and lead to new possibilities.

Battelle is an independent nonprofit organization dedicated to advancing science and technology to address the world's most pressing challenges. With over 90 years of experience, Battelle transforms knowledge into profound innovation, reinvesting its proceeds into scientific advancement and STEM education. The organization operates across various markets, including health, national security, environment, infrastructure, and industry, providing solutions through limitless innovation and expertise in scientific and engineering disciplines.

CRO Medical is dedicated to eliminating preventable deaths by developing best-in-class tools that enhance critical care at the point of injury. The company focuses on designing professional tools that empower medical providers to deliver critical care efficiently and effectively. With a commitment to quality and innovation, CRO Medical aims to equip individuals with the necessary tools and knowledge to save lives, particularly in pre-hospital and austere environments.

TechConnect is dedicated to catalyzing innovation for positive change by connecting technologists, entrepreneurs, government leaders, and industry stakeholders. The organization facilitates partnerships and collaboration through events, challenges, and innovation programs, aiming to address critical challenges across various sectors including smart cities, advanced manufacturing, and space technology.

Northeastern University is a global research university founded in 1898, renowned for its experiential learning model, high-impact research, and deep partnerships. The university emphasizes innovative teaching and research that engage students, faculty, and alumni in solving real-world problems, fostering a dynamic and inclusive community across its 13 campuses worldwide.

The Edward Via College of Osteopathic Medicine (VCOM) is dedicated to preparing globally minded, community-focused osteopathic physicians to meet the needs of rural and medically underserved populations. VCOM emphasizes research to improve human health and offers a comprehensive medical education across its campuses in Virginia, South Carolina, Alabama, and Louisiana.

The Center for Combat Medicine and Battlefield (COMBAT) Research is a lab within the University of Colorado, Denver that is dedicated to solving the U.S. military’s toughest medical challenges by leading high-impact research, education, and innovation. The center collaborates with government, academic, and industry partners to turn military medical gains into better healthcare for all. It focuses on combat and deployment-related medical research, leveraging over 100 years of combined military experience to address current military medicine research gaps and translate solutions to civilian communities. The center also emphasizes the importance of education and mentorship in advancing the next generation of military physicians and researchers.

Rebel Medicine is a science-led pharmaceutical company dedicated to revolutionizing acute pain management by developing innovative, non-opioid solutions. Their mission is to create impactful products that improve patient outcomes and reduce healthcare costs. By leveraging novel drug delivery technologies, Rebel Medicine aims to provide effective pain management solutions that eliminate the need for opioids, thus addressing a significant unmet medical need in acute and postoperative pain management.

Texas Biomedical Research Institute is dedicated to pioneering and sharing scientific breakthroughs to protect global communities from infectious diseases. With over 80 years of experience, it combines high-level biocontainment labs, a National Primate Research Center, and a commitment to advancing diagnostics, vaccines, and therapies. The institute also emphasizes education and outreach, providing resources and programs to engage students and teachers in scientific research.

Plas-Free Ltd is a clinical stage HealthTech company specialized in the development and commercialization of vital fluid absorbent devices for blood purification. Founded in 2017, the company focuses on innovative solutions to improve health outcomes and reduce healthcare costs. Their product pipeline aims to address unmet medical needs, particularly in the treatment of massive bleeding and hyperammonemia. The company has demonstrated significant efficacy in reducing bleeding through its ClearPlasma device, which has shown to decrease blood loss by more than 50% in pre-clinical trials.

RxMP Therapeutics is dedicated to developing innovative therapies aimed at preventing and treating hemorrhage and excessive bleeding. The company focuses on creating novel hemostatic agents that can effectively stop bleeding while minimizing the risk of unwanted clotting elsewhere in the body. Their lead product, RMP-402, has significant market potential and is backed by substantial funding to support its development.

Legacy Innovation Inc. is a visionary company focused on inventing groundbreaking technologies and products in pressure, temperature, and flow. With a diverse team of entrepreneurs, inventors, and engineers, the company has successfully pivoted from the beverage industry to medical device innovation during the pandemic, showcasing its versatility and commitment to excellence across various sectors.

Texas Christian University (TCU) is dedicated to fostering a vibrant research environment that supports faculty, staff, and students in their scholarly pursuits. The university emphasizes a teacher-scholar model, integrating teaching and research to address significant social and physical challenges. TCU's Office of Sponsored Programs provides essential support for securing external funding and ensuring compliance with research regulations, promoting innovative research and creative activities across various disciplines.

Florida State University (FSU) is a preeminent research university located in Tallahassee, Florida, dedicated to excellence in teaching, research, and service. Founded in 1851, FSU offers a diverse range of undergraduate, graduate, and professional programs, with a strong emphasis on liberal arts and sciences. The university is recognized for its commitment to diversity, inclusion, and student success, and it boasts a vibrant campus life with numerous opportunities for academic and extracurricular engagement.

Rosalind Franklin University (RFU) is dedicated to advancing healthcare education and research through interprofessionalism and innovative practices. Named after Dr. Rosalind Franklin, the university fosters a collaborative environment for students and faculty to improve health outcomes and community wellness.

Clean Beam Technologies, LLC is dedicated to revolutionizing wound care through innovative technology. Their mission is to provide safe and effective solutions that enhance patient outcomes and improve healthcare practices, particularly focusing on wound sterilization using safe Far UVC light.

Delta Development Team is a pioneering force in Transportable Blood Storage Solutions, focusing on advanced thermal system technology and real-time monitoring capabilities. The company is dedicated to maintaining high quality standards through rigorous testing, FDA listing, and comprehensive regulatory certifications, aiming to revolutionize prehospital healthcare for military and emergency medical settings.

SelSym Biotech is dedicated to developing innovative therapeutics to address critical clinical needs in hemorrhage control, surgical bleeding, and wound healing. Their mission is to transform patient care and outcomes through advanced technologies like their Hemostatic Healing Hydrogels and SymClot, a novel therapy that mimics platelet functions to enhance hemorrhage control and address platelet supply shortages.

Tunnell Government Services, Inc. is a subsidiary of Tunnell Consulting, Inc., dedicated to providing professional services to government agencies. The company focuses on transforming organizations to achieve sustainable results and fulfill agency missions. With expertise in public health preparedness, biodefense lab support, and scientific project portfolio management, Tunnell Government Services partners with government organizations to address the greatest threats to public health and enhance organizational performance.

Automedicus Corporation, Inc. is a medical device firm that has invented and is developing a transformative blood pressure management device called AutoPress. This device aims to provide a low-cost solution for managing blood pressure volatility, which is a significant issue in various medical settings, particularly during surgeries.

The Office of Sponsored Programs (OSP) at Georgia Tech provides comprehensive support for research administration, including proposal preparation, contract negotiation, and compliance with federal and state regulations. OSP aims to facilitate research by offering educational resources, guidance, and administrative support to faculty and research administrators throughout the award lifecycle. Additionally, OSP is committed to improving and modernizing contract management processes, ensuring compliance with various agreements, and fostering collaborative research efforts.

Rx Bandz is dedicated to developing innovative, next-generation auto-injectors and life-saving formulations that provide simple solutions for patients, first responders, and the military. Their mission is to enhance the delivery of injectable medications, ensuring accessibility and ease of use for anyone, anytime, anywhere.

Advanced Technology International (ATI) is a leading organization that builds and manages R&D collaborations to address the nation's most pressing challenges with speed and innovation. As the largest driver of R&D innovation annually in the U.S., ATI connects government agencies with top innovators to accelerate technological progress and access emerging technologies. With over 25 years of experience, ATI supports projects with significant national security impacts across various sectors, including aviation, armaments, biomedical, and shipbuilding. ATI is renowned for its expertise in managing Other Transaction Agreements (OTAs), which facilitate partnerships between industry, academia, and government, enabling non-traditional contractors to participate in technology development.

Athena GTX is dedicated to advancing wireless, mobile, patient-worn monitoring solutions for both military and civilian markets. The company focuses on connecting patients and providers through state-of-the-art medical and communication technology, developed and produced in Iowa. Athena GTX aims to enhance patient outcomes by integrating innovative wireless technology with reliable devices, supporting first responders and medical professionals in various challenging environments.

Prytime Medical Devices, Inc. is an innovative medical device company that designs, develops, and commercializes minimally invasive solutions for hemorrhage control, particularly through the use of the Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) technique. The company aims to improve survival rates in trauma situations where hemorrhage is the leading cause of potentially survivable death. Prytime is committed to revolutionizing the care of severely injured patients by enabling trauma teams to gain control of life-threatening bleeding as a bridge to definitive repair.

Colorado State University (CSU) is dedicated to providing a transformative educational experience that inspires students to reach their full potential. With a commitment to sustainability, inclusivity, and research innovation, CSU fosters a vibrant community where students can explore diverse academic programs and engage in meaningful research and extracurricular activities.

Wake Forest University School of Medicine is a leading institution dedicated to advancing medical education, research, and patient care. With a focus on preparing the next generation of healthcare leaders, the school offers a comprehensive range of programs and fosters a culture of innovation and excellence. The institution is recognized for its nationally acclaimed research programs and commitment to compassionate, collaborative care. The school is also a catalyst for economic development through its Wake Forest Innovation Quarter, providing state-of-the-art facilities and a vibrant environment for education and research.

ReBlood Rx is dedicated to innovating oxygen therapy through hemoglobin-based solutions, aiming to provide a safe, effective, and reliable oxygen delivery system in medical emergencies where blood transfusions are not an option. Their mission focuses on improving patient outcomes in critical care settings and addressing the challenges of blood supply shortages in both human and veterinary medicine.

Sciperio Inc. is a pioneering research and development company at the forefront of physical and biological innovation. With a transdisciplinary engineering approach, Sciperio excels in mechanical, chemical, electrical, and biological sciences, pushing the boundaries of traditional scientific fields to develop next-generation technologies. The company is committed to advancing technology for the betterment of humankind, with core capabilities in additively manufactured electronics, mechatronics, machine learning, printed electronics, and biological engineering. Sciperio's mission is to research new concepts and develop technologies that connect people, mobilize businesses, and enhance life through advanced technology.

Octapharma USA is a leading healthcare company dedicated to providing innovative health solutions that advance human life. As the largest privately owned plasma fractionator globally, Octapharma develops and manufactures high-quality human proteins sourced from human plasma and cell lines, focusing on hematology, immunotherapy, and critical care. The company is committed to patient engagement and community support, ensuring that their products meet the highest safety and quality standards.

MedTech Innovator is the world's largest accelerator for medical device, digital health, and diagnostic companies. Their mission is to improve patients' lives by accelerating the growth of companies transforming healthcare worldwide. They offer programs and resources to support innovators in the medtech industry, including webinars, fellowships, and strategic partnerships.

Founded in 2018 in Baltimore, BC3 Technologies is a minority-owned enterprise dedicated to revolutionizing emergency medical response. The company focuses on addressing critical gaps in emergency medical care, particularly in the management of life-threatening arterial bleeding, through innovative hemostatic solutions. BC3 Technologies aims to save lives by providing efficient, effective, and accessible products for medical, military, and general consumer sectors.

KaloCyte, Inc. is a pre-clinical stage biotech company focused on developing ErythroMer™, a dried, bio-inspired artificial red blood cell that is shelf-stable without refrigeration. This innovative solution aims to address the critical need for blood substitutes in emergency situations where stored red blood cells are unavailable, undesirable, or in short supply. Founded by a team of experts in physiology, bioengineering, and trauma care, KaloCyte is supported by significant federal grants and investor funding, positioning it to advance to first-in-human trials.

ARIScience is at the forefront of drug discovery, leveraging a unique combination of AI, quantum chemistry, computer vision, and biochemistry to develop novel small molecule drugs. Their mission is to reduce the burden of human disease by discovering therapeutics that interrupt disease pathways. With a focus on neurodegenerative, inflammatory, and infectious diseases, ARIScience employs cutting-edge in silico methods to efficiently identify and optimize drug candidates. Their commitment to innovation and collaboration with leading institutions positions them to make a significant impact on human health.

The Geneva Foundation is a 501(c)3 nonprofit established in 1993, dedicated to advancing military medicine through research, development, and education. With a commitment to ensuring optimal health for service members and the communities they serve, Geneva collaborates with various partners to drive innovative medical research and improve healthcare outcomes.

Exthera Medical is committed to utilizing advanced technology to enhance healthcare services, focusing on personalized ads and content delivery through data processing. The company emphasizes responsible data use, ensuring user privacy and consent management. They employ cookies and other tracking methods to deliver personalized advertising and content, while maintaining a strong focus on data security and user privacy.

Zymeron is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative healthcare technologies that deliver step-change performance. The company focuses on proactive health solutions to address critical unmet needs in the pharmaceutical sciences, particularly in drug delivery and formulation technologies.

Compression Works is dedicated to developing innovative solutions for hemorrhage control, particularly through their flagship product, the Abdominal Aortic & Junctional Tourniquet-Stabilized (AAJT-S). The company aims to meet the urgent needs of emergency healthcare providers and is committed to research and technology that enhances life-saving care. As a veteran-owned business, Compression Works focuses on providing effective bleeding control solutions used by military and emergency services worldwide.

Omniox is an IND-stage biotherapeutics company focused on developing innovative H-NOX platform technology into first-in-class and best-in-class OMX oxygen delivery vehicles. These biologics are designed to safely deliver oxygen to hypoxic tissues, addressing significant unmet medical needs and improving patient outcomes.

The Coalition for National Trauma Research (CNTR) is dedicated to saving lives and reducing disability through trauma research. Their mission focuses on coordinating research efforts, strengthening infrastructure for multi-center investigations, and advocating for sustainable research funding to address the burden of traumatic injuries.

The Center for Military Medicine Research (CMMR) at the University of Pittsburgh is dedicated to advancing medical research for wounded service members and their families. The center focuses on trauma, emergency, and critical care, leveraging the university's strengths in medical and engineering fields, and collaborating with Carnegie Mellon University's robotics and AI expertise. CMMR aims to enhance trauma care for warfighters and civilians, contributing to the defense innovation economy.

Duke University is a prestigious institution located in Durham, North Carolina, known for its commitment to academic excellence, research innovation, and community engagement. The university offers a wide range of undergraduate and graduate programs across various disciplines, fostering a diverse and inclusive environment for students, faculty, and staff.